Dialysis access graft occlusion with contrast and ultrasound guided thrombin injection for intractable arm edema and pseudoaneurysm

J Vasc Access. 2023 Jul;24(4):798-801. doi: 10.1177/11297298211047330. Epub 2021 Sep 30.

Abstract

We present the case of a patient with a brachio-basilic graft forearm loop with intractable edema and thrombosed central veins. She showed up with an important edema after some effort and a previously thrombosed pseudoaneurysm with significant growth. She refused angioplasty treatment for central veins, the graft had not been used for dialysis during the last year, so that arteriovenous graft (AVG) ligation was considered. Due to local conditions thrombin percutaneous embolization was performed to avoid possible complications of a conventional surgery approach. AVG occlusion was done in 10 min by fluoroscopy and ultrasound guidance. In 24 h the patient was significantly better and after 1 week she had no edema at all. There were no complications and no recanalization was observed after 3 months. Percutaneous thrombin embolization is a safe and effective technique for AVG occlusion in case of intractable arm edema with central vein thrombosis, and most likely to be considered in other situations where arteriovenous graft or fistula ligature is needed.

Keywords: Arteriovenous closure; arteriovenous embolization; arteriovenous ligation; dialysis access; percutaneous thrombin; thrombin embolization; venous hypertension.

Publication types

  • Case Reports

MeSH terms

  • Aneurysm, False* / diagnostic imaging
  • Aneurysm, False* / etiology
  • Aneurysm, False* / therapy
  • Arm
  • Arteriovenous Shunt, Surgical* / adverse effects
  • Arteriovenous Shunt, Surgical* / methods
  • Edema / complications
  • Female
  • Graft Occlusion, Vascular / diagnostic imaging
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / therapy
  • Humans
  • Renal Dialysis
  • Retrospective Studies
  • Thrombin
  • Thrombosis*
  • Treatment Outcome
  • Ultrasonography, Interventional
  • Vascular Diseases* / complications
  • Vascular Patency

Substances

  • Thrombin